Independent technical consultancy. Microfluidics, single cell analysis and product development. Start a conversation.
The laboratory is being atomised.
For as long as anyone has been buying them, the instrument has been the unit. A box that does one workflow well, bought whole and replaced whole. What is arriving instead is a laboratory assembled from minimally functional units that can be rearranged as the question changes.
That changes what an instrument has to be. It has to be addressable rather than operable. It has to be deterministic before it is flexible. And it has to describe itself to the software that will schedule it, rather than wait for a person to interpret it.
Most of the tools being sold today were designed before any of that was true. Atomixel does not build the replacements. My work is helping the people who do, and the people who have to choose between them.
These are the questions clients arrive with, across microfluidics, single cell analysis, instrument hardware, software and the assay in between. The answer comes as written work, as hands on time with your team, or as training so they can do it themselves. I have taken a platform of this kind from the first experiment through to a product that customers run without me.
It works in a paper. Will it work as an instrument someone can buy, run and service?
What is this for, who pays for it, and what makes it hard to copy?
We have a platform. What is the product, and what has to be true before we commit?
We know what to build. How does it actually get made, in what order, and by whom?
It works in our hands. Why does it not work in theirs?
Xin Liu, PhD
Founder and Consultant
Fifteen years taking scientific instrumentation from concept to commercial product. Co-inventor of a picodroplet single cell platform and one of the team that took it to market. Microfluidics, single cell analysis, instrument hardware, software and automated workflows, end to end.
You will not need to explain the physics to me and then explain the business case to someone else. That is what makes a short engagement productive rather than a long induction.
In person
ELRIG Drug Discovery
14 and 15 October
ExCeL London
Consultants Cafe